Analyst Ratings for Ascendis Pharma (ASND)
ASND Rating Summary
ASND Price Target Summary
- Highest: $360.00 (Citi)
- Lowest: $255.00 (Goldman Sachs)
- Average: $307.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$307.20 (+36.4%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
Rating Score: 9.6 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2026 | Raymond James | Martin Auster | Downgrade | Outperform (Strong Buy) |
287.00 (N/A) |
263.51 (225.25) |
-14.52% | Details |
| 8/27/2026 | H.C. Wainwright » Updated 9/16/2026 |
Mitchell S. Kapoor | New Coverage | Buy (N/A) |
344.00 (N/A) |
250.25 (225.25) |
-9.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
